These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase. van der Laan JW, de Boer T, Bruinvels J. J Neurochem; 1979 Jun 16; 32(6):1769-80. PubMed ID: 376783 [No Abstract] [Full Text] [Related]
11. Essential arginine residues at the pyridoxal phosphate binding site of brain gamma-aminobutyrate aminotransferase. Tunnicliff G. Biochem Biophys Res Commun; 1980 Nov 17; 97(1):160-5. PubMed ID: 7458930 [No Abstract] [Full Text] [Related]
13. Further evidence for the existence of isozymes of brain gamma-aminobutyrate aminotransferase. Ngo TT, Tunnicliff G. Comp Biochem Physiol C Comp Pharmacol; 1978 Nov 17; 59(2):101-4. PubMed ID: 25733 [No Abstract] [Full Text] [Related]
15. Effects of chronic treatment with amino-oxyacetic acid or sodium n-dipropylacetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats. Emson PC. J Neurochem; 1976 Dec 17; 27(6):1489-94. PubMed ID: 794443 [No Abstract] [Full Text] [Related]
16. Mechanism-based inactivation of GABA aminotransferase by 3,5-dioxocyclohexanecarboxylic acid. Alston TA, Porter DJ, Wheeler DM, Bright HJ. Biochem Pharmacol; 1982 Dec 15; 31(24):4081-4. PubMed ID: 7159484 [No Abstract] [Full Text] [Related]
17. omega-Fluoromethyl analogues of omega-amino acids as irreversible inhibitors of 4-aminobutyrate:2-oxoglutarate aminotransferase. Bey P, Jung MJ, Gerhart F, Schirlin D, Van Dorsselaer V, Casara P. J Neurochem; 1981 Nov 15; 37(5):1341-4. PubMed ID: 6795312 [Abstract] [Full Text] [Related]